Sunnyvale, CA – According to filings with the U.S. Securities and Exchange Commission, eNeura Inc. is raising $6,284,105.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, David Rosen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About eNeura Inc.

eNeura Inc., a privately-held medical technology company, is pioneering the use of portable, non-invasive transcranial magnetic stimulation (TMS) devices for treatment of migraine. Prescribed by physicians but designed for patient use, the sTMS mini is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as neededùat home, in the office, or on the go. Eneura is located in Sunnyvale, California. This organization primarily operates in the Hospital Equipment and Supplies. eNeura helps you stay in control of your days with personal support. Throughout your migraine treatment with the sTMS mini, advice and assistance are available at no cost to you.

To learn more about eNeura Inc., visit http://www.eneura.com/

Contact:
David Rosen, President and Chief Executive Officer
408-245-6400
drosen@eneura.com
https://www.linkedin.com/in/david-rosen-8624326/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved